% | $
Quotes you view appear here for quick access.

Impax Laboratories Inc. (IPXLE) Message Board

  • shmori shmori Jul 25, 2003 6:19 PM Flag

    A question for the IPXL pros

    I am still not in yet but interested. I was wondering about all the attention that Wellbutrin SR� is getting here so I went and looked it up! Based on the company's own press release (see below) the total sales of Wellbutrin SR� was only 46mil/entire year!! Even assuming iPXL gets the whole thing, it's not a very minimal drug! Please let me know if I am missing something.. Thanks

    May 28, 2003 -- IMPAX Laboratories, Inc. (Nasdaq:IPXL) today announced that the United States Food and Drug Administration (FDA) has accepted the Company�s filing of an Abbreviated New Drug Application (ANDA) for a generic version of Wellbutrin SR� (Bupropion Hydrochloride) 200mg Tablets. GlaxoSmithKline (Glaxo) markets Wellbutrin SR� for the treatment of depression. U.S. sales of Wellbutrin SR� 200mg Tablets were approximately $46 million in the twelve months ended December 31, 2002, according to IMS Health. Glaxo received FDA approval of this product in June 2002.

    SortNewest  |  Oldest  |  Most Replied Expand all replies